J. Biochem, 1988, Vol. 103, No. 5 815-819
© 1988 Japanese Biochemical Society
research-article |
Hydrolysis of Platelet Activating Factor and Its Methylated Analogs by Acetylhydrolases1
The University of Tokyo Bunkyo-ku, Tokyo 113
We examined the substrate specificity of PAF-degrading enzymes from various sources using platelet activating factor (PAF) and its synthetic analogs. The results were as follows: 1) Tissue-originated acetylhydrolases, such as rat kidney soluble enzyme, deacetylated 1S-methyl-1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (1S-Me-PAF) slightly more rapidly than PAF, whereas plasma acetylhydrolase hydrolyzed PAF more effectively than 1S-Me-PAF. 2) Rat polymorphonuclear leukocytes, monocytes, and lymphocytes homogenates showed an appreciable acetylhydrolase activity, the substrate specificity of which resembled that of the plasma enzyme. 3) Pleural exudates in an experimental pleurisy induced in rats by carrageenan contained an acetylhydrolase activity, the properties of which were similar to those of the plasma enzyme. 4) An extracellular phospholipase A2 activity, which was also observed in the pleural exudate and required Ca2+ ion for maximum activity, seemed not to participate in the deacetylation of PAF, since addition of EDTA did not affect the PAF deacetylation catalyzed by the pleural exudate. These findings indicate that the inactivation reaction of PAF present in the extracellular space is mainly catalyzed by plasma acetylhydrolase, which yields lysoPAF.
1This work is supported in part by Grants-in-Aid for Scientific Research (Nos. 60880018, 61106008, and 61571046) from the Ministry of Education, Science and Culture of Japan.
2 Present address: Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko-machi, Tsukui-gun, Kanagawa 199–01.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Boilard, S. G. Bourgoin, C. Bernatchez, and M. E. Surette Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2 Blood, October 15, 2003; 102(8): 2901 - 2909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yasuda, T. Okumura, H. Okada, T. Nakajima, J. Aoki, H. Arai, K. Inoue, M. Nishizawa, S. Ito, and H. Kanzaki Platelet-Activating Factor Acetylhydrolase Isoforms I and II in Human Uterus. Comparisons with Pregnant Uterus and Myoma Biol Reprod, January 1, 2001; 64(1): 339 - 344. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y.S. Ho, P.J. Sheffield, J. Masuyama, H. Arai, J. Li, J. Aoki, K. Inoue, U. Derewenda, and Z.S. Derewenda Probing the substrate specificity of the intracellular brain platelet-activating factor acetylhydrolase Protein Eng. Des. Sel., August 1, 1999; 12(8): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Manya, J. Aoki, M. Watanabe, T. Adachi, H. Asou, Y. Inoue, H. Arai, and K. Inoue Switching of Platelet-activating Factor Acetylhydrolase Catalytic Subunits in Developing Rat Brain J. Biol. Chem., July 17, 1998; 273(29): 18567 - 18572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Matsuzawa, K. Hattori, J. Aoki, H. Arai, and K. Inoue Protection against Oxidative Stress-induced Cell Death by Intracellular Platelet-activating Factor-Acetylhydrolase II J. Biol. Chem., December 19, 1997; 272(51): 32315 - 32320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hattori, M. Hattori, H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue Purification and Characterization of Platelet-activating Factor Acetylhydrolase II from Bovine Liver Cytosol J. Biol. Chem., September 22, 1995; 270(38): 22308 - 22313. [Abstract] [Full Text] [PDF]
|
|